Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis (1998–2020)
Peter Thelma Ngwa Niba,Akindeh M. Nji,Marie-Solange Evehe,Innocent M. Ali,Palmer Masumbe Netongo,Randolph Ngwafor,Marcel N. Moyeh,Lesley Ngum Ngum,Oliva Ebie Ndum,Fon Abongwa Acho,Cyrille Mbanwi Mbu’u,Dorothy A. Fosah,Barbara Atogho-Tiedeu,Olivia Achonduh-Atijegbe,Rosine Djokam-Dadjeu,Jean Paul Kengne Chedjou,Jude D. Bigoga,Carole Else Eboumbou Moukoko,Anthony Ajua,Eric Achidi,Esther Tallah,Rose G. F. Leke,Alexis Tourgordi,Pascal Ringwald,Michael Alifrangis,Wilfred F. Mbacham
DOI: https://doi.org/10.1186/s12936-020-03543-8
2021-01-09
Malaria Journal
Abstract:Abstract Background Malaria remains highly endemic in Cameroon. The rapid emergence and spread of drug resistance was responsible for the change from monotherapies to artemisinin-based combinations. This systematic review and meta-analysis aimed to determine the prevalence and distribution of Plasmodium falciparum drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon from January 1998 to August 2020. Methods The PRISMA-P and PRISMA statements were adopted in the inclusion of studies on single nucleotide polymorphisms (SNPs) of P . falciparum anti-malarial drug resistance genes ( Pfcrt , Pfmdr1 , Pfdhfr , Pfdhps , Pfatp6 , Pfcytb and Pfk13 ). The heterogeneity of the included studies was evaluated using the Cochran’s Q and I 2 statistics. The random effects model was used as standard in the determination of heterogeneity between studies. Results Out of the 902 records screened, 48 studies were included in this aggregated meta-analysis of molecular data. A total of 18,706 SNPs of the anti-malarial drug resistance genes were genotyped from 47,382 samples which yielded a pooled prevalence of 35.4% (95% CI 29.1–42.3%). Between 1998 and 2020, there was significant decline (P < 0.0001 for all) in key mutants including Pfcrt 76 T (79.9%-43.0%), Pfmdr1 86Y (82.7%-30.5%), Pfdhfr 51I (72.2%-66.9%), Pfdhfr 59R (76.5%-67.8%), Pfdhfr 108 N (80.8%-67.6%). The only exception was Pfdhps 437G which increased over time (30.4%-46.9%, P < 0.0001) and Pfdhps 540E that remained largely unchanged (0.0%-0.4%, P = 0.201). Exploring mutant haplotypes, the study observed a significant increase in the prevalence of Pfcrt CVIET mixed quintuple haplotype from 57.1% in 1998 to 57.9% in 2020 (P < 0.0001). In addition, within the same study period, there was no significant change in the triple Pfdhfr IRN mutant haplotype (66.2% to 67.3%, P = 0.427). The Pfk13 amino acid polymorphisms associated with artemisinin resistance were not detected. Conclusions This review reported an overall decline in the prevalence of P. falciparum gene mutations conferring resistance to 4-aminoquinolines and amino alcohols for a period over two decades. Resistance to artemisinins measured by the presence of SNPs in the Pfk13 gene does not seem to be a problem in Cameroon. Systematic review registration PROSPERO CRD42020162620
infectious diseases,tropical medicine,parasitology